Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function

Archives of Neurology

Volumn 61, Issue 5, 2004, Pages 661-666

  Arvanitakis, Zoe ^a,b   Wilson, Robert S ^a,b   Bienias, Julia L ^b,c   Evans, Denis A ^b,c   Bennett, David A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; DEPTH PERCEPTION; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; REGISTER; RISK FACTOR;

ALZHEIMER DISEASE; COGNITION DISORDERS; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 2442424380     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.5.661     Document Type: Article

References (40)

1. National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2000. Bethesda, Md: US Dept of Health and Human Services, National Institutes of Health; 2002.
2. Desmond DW, Tatemichi TK, Paik M, Stern Y. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol. 1993;50:162-166.
3. Croxson SC, Jagger C. Diabetes and cognitive impairment: a community-based study of elderly subjects. Age Ageing. 1995;24:421-424.
4. Grodstein F, Chen J, Wilson RS, Manson JE, Nurses' Health Study. Type 2 diabetes and cognitive function in communily-dwelling elderly women. Diabetes Care. 2001;24:1060-1065.
5. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology. 1999;53: 1937-1942.
6. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies. Diabetes. 2002;51:1256-1262.
7. Luchsinger JA, Tang MX, Stem Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001;154:635-641.
8. MacKnight C, Rockwood K, Await E, McDowell I. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord. 2002;14:77-83.
9. Gregg EW, Yaffe K, Cauley JA, et al. Study of Osteoporotic Fractures Research Group. Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch Intern Med. 2000;160:174-180.
10. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care. 2001;24: 366-370.
11. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56:42-48.
12. Robertson-Tchabo EA, Arenberg D, Tobin JD, Plotz JB. A longitudinal study of cognitive performance in noninsulin dependent (type II) diabetic men. Exp Gerontol. 1986;21:459-467.
13. Wilson RS, Schneider JA, Barnes LL, et al. The apolipoprotein E ε4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol. 2002; 59:1154-1160.
14. Wilson RS, Barnes LL, Mendes de Leon CF, et al. Depressive symptoms cognitive decline, and risk of AD in older persons. Neurology. 2002;59:364-370.
15. Schneider JA, Wilson RS, Cochran EJ, et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology. 2003;60:1082-1088.
16. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part I. Neurology. 1989;39:1159-1165.
17. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59:198-205.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadian EM. Clinical diagnosis of Alzheimer's disease. Neurology. 1984;34:939-944.
19. Wilson RS, Beckett LA, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychology Aging. 2002;17:179-193.
20. Wilson RS, Mendes de Leon CF, Barnes LL, et al. Participation in cognitive stimulating activities and risk of incident Alzheimer disease. JAMA 2002;287:742-748.
21. Welsh KA, Butters N, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part V. Neurology. 1994;44:609-614.
22. SAS Institute Inc. SAS/STAT User's Guide, Version 8: Software Manual. Cary, NC: SAS Institute Inc; 2000.
23. Bennett DA, Wilson RS, Schneider JA, et al. Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology. 2003;60: 246-252.
24. Wilson RS, Bennett DA, Beckett LA, et al. Cognitive activity in older persons from a geographically defined population. J Gerontol B Psychol Sci Soc Sci. 1999;54: P155-P160.
25. Hebert LE, Wilson RS, Gilley DW, et al. Decline of language among women and men with Alzheimer's disease. J Gerontal B Psychol Sci Soc Sci. 2000;55:P354-P360.
26. Wilson RS, Beckett LA, Bennett DA, Albert MS, Evans DA. Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. Arch Neurol. 1999;56:1274-1279.
27. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187-220.
28. Heitner J, Dickson D. Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. Neurology. 1997;49:1306-1311.
29. Craft S, Asthana S, Newcomer JW, et al. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry. 1999; 56:1135-1140.
30. Craft S, Peskind E, Schwartz MW, Schellenberg GD, Rashkind M, Porte D Jr. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology. 1998;50:164-168.
31. Boyt AA, Taddei TK, Hallmayer J, et al. The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein. Neuroscience. 2000;95:727-734.
32. Bertram L, Blacker D, Mullin K, et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science. 2000;290:2302-2303.
33. Ertekin-Taner N, Graff-Radford N, Younkin LH, et al. Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science. 2000;290:2303-2304.
34. Chesneau V, Vekrellis K, Rosner MR, Selkoe DJ. Purified recombinant insulin-degrading enzyme degrades amyloid β-protein but does not promote its oligomerization. Biochem J. 2000;351(pt 2):509-516.
35. Vekrellis K, Ye Qiu WQ, et al. Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin-degrading enzyme. J Neurosci. 2000;20: 1657-1665.
36. Farris W, Mansourian S, Chang Y, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A. 2003;100:4162-4167.
37. Hong M, Lee VM. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem. 1997;272:19547-19553.
38. Lesort M, Johnson GV. Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons. Neuroscience. 2000;99:305-316.
39. Sasaki N, Fukatsu R, Tsuzuki K, et al. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol. 1998;153: 1149-1155.
40. Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH. Ageing and diabetes: implications for brain function. Eur J Pharmacol. 2002;441:1-14.